Main article

Health care providers, including laboratories and pathologists, face restrictions on their sales and marketing practices that many other professionals do not have to contend with. Violation of key laws can result in substantial financial penalties, warns Hope Foster, an attorney with Mintz Levin (Washington, D.C.).

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 2010 - Table of Contents

Industry Buzz: MedPAC Considers Removing Some Lab Tests from In-Office Ancillary Services Exception

Lab Index Continues Winter Slump; Down 10% Over Last Five Weeks

Time Ticking as Physician Fee Cut Freeze Expires on March 1; Congress’s Next Move Remains Unclear

Carilion-Spectrum Merger to Shake Up Lab Industry’s Duopolistic Stronghold in Mid-Atlantic and Southern Regions

LabCorp’s Q409 Revenues Up 3.4% to $1.16 Billion; Economy Still Challenges Volume Growth in 2010

Inside the Lab Industry: Managing Risk in Lab Sales and Marketing: Nine Rules to Sell By

Bostwick Shutters AIPL after Only Six Months; Announces Tenn. Closure

Myriad Genetics Emerges as Early Leader in G-2’s Preliminary FY09 Benchmarking Analysis

Baylor Health Care Launches Joint Venture with US Oncology

Oral Arguments Heard in Gene Patents Lawsuit

LIR March 2010 (Full PDF Issue)